株探米国株
日本語 英語
エドガーで原本を確認する
false 0001328792 0001328792 2025-04-08 2025-04-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 8, 2025

 

TECHPRECISION CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-41698   51-0539828

(State or Other Jurisdiction

of Incorporation or Organization)

  (Commission File Number)   (IRS Employer Identification No.)

 

1 Bella Drive

Westminster, MA 01473

(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number, including area code: (978) 874-0591

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each
exchange on which registered
Common Stock, par value $0.0001 per share TPCS Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   
¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   
¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   
¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


 

 

Item 2.02 Results of Operations and Financial Condition.

 

On April 8, 2025, TechPrecision Corporation issued a press release announcing its financial results for the third quarter ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference.

 

Item 9.01 Financial Statements and Exhibits.

 

  (d) Exhibits

 

Exhibit
Number
  Description
99.1   Press Release dated April  8, 2025
104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TECHPRECISION CORPORATION
     
Date: April 8, 2025 By: /s/ Alexander Shen
  Name: Alexander Shen
  Title: Chief Executive Officer
    (Principal Executive Officer)

 

 

 

EX-99.1 2 tm2511818d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Company Contact: Investor Relations Contact:
Alexander Shen Hayden IR
Chief Executive Officer Brett Maas
TechPrecision Corporation Phone: 646-536-7331
Phone: 978-883-5108 Email: brett@haydenir.com
Email: Shena@Ranor.com Website: www.haydenir.com
Website: www.TechPrecision.com  

 

FOR IMMEDIATE RELEASE

 

TechPrecision Corporation Reports FY 2025 Third Quarter Financial Results

 

Ranor records another profitable quarter, customer confidence remains high

Management to host conference call at 4:30 p.m. ET on Tuesday, April 8, 2025

 

Westminster, MA – April 8, 2025– TechPrecision Corporation (NASDAQ: TPCS) (“TechPrecision” or “the Company”), a custom manufacturer of precision, large-scale fabrication components and precision, large-scale machined metal structural components, today reported financial results for the third quarter ended December 31, 2024. The components that we manufacture are customer designed and we sell to customers in two main industry sections: defense and precision industrial markets.

 

Management will host a conference call on Tuesday, April 8, 2025 at 4.30 p.m. ET, to discuss our financial results for the quarter ended December 31, 2024.

 

“Third quarter consolidated revenue was $7.6 million, a decrease of less than 1% when compared to the fiscal 2024 third quarter. Our fiscal third quarter is seasonally characterized with higher under-absorbed overhead. Our Ranor segment experienced a favorable project mix enabling us to sustain operating profitability. In contrast, our Stadco segment is continuing to work through remaining legacy pricing problems on core business, with an unfavorable project mix for the quarter coupled with under-absorbed overhead.” stated Alexander Shen, TechPrecision’s Chief Executive Officer. “Customer confidence remains high as our backlog was $45.5 million on December 31, 2024. We expect to deliver our backlog over the course of the next one to three fiscal years with gross margin expansion.”

 

The following summary compares the three and nine months ended December 31, 2024 to the same prior year period:

 

Consolidated Financial Results - Fiscal 2025 Three Months Ended December 31, 2024

 

· Revenue was $7.6 million, a decrease of less than 1% when compared to revenue of $7.7 million a year ago.
· Cost of revenue was $6.6 million, or 2% higher, due primarily to higher production costs at Stadco.
· Gross profit was $1.0 million, or 15% lower due primarily to higher production costs at Stadco.
· SG&A totaled $1.7 million or 22% lower due primarily to the absence of due diligence costs for acquisitions.
· Operating loss was $0.7 million  compared with a loss of $1.0 million in  the same period a year ago.
· Interest expense increased by $26,000 due primarily to an increase in borrowing under the revolver loan.
·

Net loss was $0.8 million, as the Company maintained a full valuation on its deferred tax assets.

 

Consolidated Financial Results - Fiscal 2025 Nine Months Ended December 31, 2024

 

· Revenue was $24.6 million,  or 7% higher on a favorable project mix at both Ranor and Stadco.
· Cost of revenue was $22.3 million, or 11% higher, due primarily to higher production costs at Stadco.
· Gross profit was $2.2 million, or 22% lower, primarily the result of higher Stadco production issues.
· SG&A was $4.8 million or a 6% decrease, due primarily to the absence of due diligence costs for acquisitions.

 

 


 

· Operating loss was $2.5 million, an increase of $0.4 million due to higher losses at Stadco.
· Interest expense increased by 9% due to higher borrowing under the revolver loan.
·

Net loss was $2.9 million, as the Company maintained a full valuation on its deferred tax assets.

 

 

Financial Position

 

On September 30, 2024, the Company had approximately $165,000 in cash and cash equivalents, a $27,000 increase since March 31, 2024. Working capital was negative $1.8 million on December 31, 2024 and debt totaled $7.4 million. Working capital was negative $2.9 million and total debt was $7.6 million on March 31, 2024.

 

Conference Call

The Company will hold a conference call at 4:30 p.m. Eastern (U.S.) time on Tuesday, April 8, 2025. To participate in the live conference call, please dial 1-888-506-0062 five to 10 minutes prior to the scheduled conference call time. International callers should dial 1-973-528-0011. When prompted, reference TechPrecision and enter code 538981.

 

A replay will be available until April 22, 2025. To access the replay, dial 1-877-481-4010 or 1-919-882-2331. When prompted, enter Conference Passcode 52309.

 

The call will also be available over the Internet and accessible at:
https://www.webcaster4.com/Webcast/Page/2198/52309.

 

About TechPrecision Corporation

 

TechPrecision Corporation, through its wholly owned subsidiaries, Ranor, Inc. and Stadco, The manufacturing operations of our Ranor subsidiary are situated on approximately 65 acres in North Central Massachusetts. Leveraging our 145,000 square foot facilities, Ranor provides a full range of custom solutions to transform material into precision finished welded components and precision finished machined components up to 100 tons: manufacturing engineering, materials management and traceability, high-precision heavy fabrication (in-house fabrication operations include cutting, press and roll forming, welding, heat treating, assembly, blasting and painting), heavy high-precision machining (in-house machining operations include CNC programming, finishing, and assembly), QC inspection including portable CMM, NonDestructive Testing, and final packaging.

 

All manufacturing at Ranor is performed in accordance with customer requirements. Ranor is an ISO 9001:2015 certificate holder. Ranor is a US defense-centric company with over 95% of its revenue in the defense sector. Ranor is registered and compliant with ITAR.

 

The manufacturing operations of our Stadco subsidiary are situated in an industrial self-contained multi-building complex comprised of approximately 183,000 square feet under roof in Los Angeles, California. Stadco manufactures large mission-critical components on several high-profile military aircraft, military helicopter, and military space programs. Stadco has been a critical supplier to a blue-chip customer base that includes some of the largest OEMs and prime contractors in the defense and aerospace industries. Stadco also manufactures tooling, molds, fixtures, jigs and dies used in the production of defense-centric aircraft components.

 

Our Stadco subsidiary, similar to Ranor, provides a full range of custom solutions: manufacturing engineering, materials management and traceability, high-precision fabrication (in-house fabrication operations include waterjet cutting, press forming, welding, and assembly) and high-precision machining (in-house machining operations include CNC programming, finishing, and assembly), QC inspection including both fixed and portable CMM NonDestructive Testing, and final packaging. In addition, Stadco features a large electron beam welding cell, and two NonDestructive Testing work cells, a unique mission-critical technology set.

 

All manufacturing at Stadco is performed in accordance with customer requirements. Stadco is an AS 9100 D and ISO 9001:2015 certificate holder and a NADCAP NonDestructive Testing certificate holder. Stadco is a US defense-centric company with over 60% of its revenue in the defense sector. Stadco is registered and compliant with ITAR.

 

 


 

To learn more about the Company, please visit the corporate website at http://www.techprecision.com. Information on the Company's website or any other website does not constitute a part of this press release.

 

Safe Harbor Statement

 

This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary companies. All statements other than statements of current or historical fact contained in this press release, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “prospects,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from: our reliance on individual purchase orders, rather than long-term contracts, to generate revenue; our ability to balance the composition of our revenues and effectively control operating expenses; external factors that may be outside our control, including health emergencies, like epidemics or pandemics, the conflicts in Eastern Europe and the Middle East, price inflation, interest rate increases and supply chain inefficiencies; the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity; our ability to receive contract awards through competitive bidding processes; our ability to maintain standards to enable us to manufacture products to exacting specifications; our ability to enter new markets for our services; our reliance on a small number of customers for a significant percentage of our business; competitive pressures in the markets we serve; changes in the availability or cost of raw materials and energy for our production facilities; restrictions in our ability to operate our business due to our outstanding indebtedness; government tariffs, regulations and requirements; pricing and business development difficulties; changes in government spending on national defense; our ability to make acquisitions and successfully integrate those acquisitions with our business; our failure to maintain effective internal controls over financial reporting; general industry and market conditions and growth rates; and other risks discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this press release, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

 

 


 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

    (Unaudited)        
    December 31,     March 31,  
( in thousands, except per share data)   2024     2024  
ASSETS                
Current assets:                
Cash and cash equivalents   $ 165     $ 138  
Accounts receivable, net     1,970       2,371  
Contract assets     8,417       8,527  
Raw materials     1,871       1,827  
Work-in-process     1,329       1,423  
Other current assets     375       564  
Total current assets     14,127       14,850  
Property, plant and equipment, net     13,463       14,798  
Right of use asset, net     4,449       4,977  
Other noncurrent assets     121       122  
Total assets   $ 32,160     $ 34,747  
LIABILITIES AND STOCKHOLDERS’ EQUITY:                
Current liabilities:                
Accounts payable   $ 1,833     $ 1,408  
Accrued expenses     3,344       4,263  
Contract liabilities     2,667       3,788  
Current portion of long-term lease liability     761       736  
Current portion of long-term debt, net     7,278       7,559  
Total current liabilities     15,883       17,754  
Long-term equipment financing     19       ---  
Long-term lease liability     3,834       4,408  
Other noncurrent liability     4,323       4,782  
Total liabilities     24,059       26,944  
Stockholders’ Equity:                
Common stock - par value $0.0001 per share, 50,000,000 shares authorized; Shares issued and outstanding December 31, 2024 – 9,662,525 and 9,607,525, respectively;  Shares issued and outstanding March 31, 2024 – 8,777,432.     1       1  
Additional paid in capital     18,359       15,201  
Accumulated deficit     (10,259 )     (7,399 )
Total stockholders’ equity     8,101       7,803  
Total liabilities and stockholders’ equity   $ 32,160     $ 34,747  

 

 


 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

    Three Months Ended December 31,     Nine Months Ended December 31,  
(in thousands, except per share data)   2024     2023     2024     2023  
Revenue   $ 7,622     $ 7,650     $ 24,554     $ 22,991  
Cost of revenue     6,631       6,489       22,310       20,101  
Gross profit     991       1,161       2,244       2,890  
Selling, general and administrative     1,687       2,157       4,769       5,063  
Loss from operations     (696 )     (996 )     (2,525 )     (2,173 )
Other income     44       ---       57       41  
Interest expense     (147 )     (110 )     (392 )     (353 )
Total other income (expense)     (103 )     (110 )     (335 )     (312 )
Loss before income taxes     (799 )     (1,106 )     (2,860 )     (2,485 )
Income tax benefit     ---       (241 )     ---       (564 )
Net loss   $ (799 )   $ (865 )   $ (2,860 )   $ (1,921 )
Net loss per share - basic and diluted   $ (0.08 )   $ (0.10 )   $ (0.30 )   $ (0.22 )
Weighted average shares outstanding – basic and diluted     9,607,785       8,759,171       9,389,346       8,698,034  

 

 


 

TECHPRECISION CORPORATION

REVENUE, COST OF REVENUE, GROSS PROFIT BY SEGMENT

  (dollars in thousands)

 

Three Months Ended

 

    December 31, 2024     December 31, 2023     Changes  
          Percent of           Percent of              
  Amount     Revenue     Amount     Revenue     Amount     Percent  
Revenue                                    
Ranor   $ 4,310       57 %   $ 4,296       56 %   $ 14       --- %
Stadco     3,312       43 %     3,370       44 %     (58 )     (2 )%
Intersegment elimination     ---       --- %     (16 )     --- %     16       100 %
Consolidated Revenue   $ 7,622       100 %   $ 7,650       100 %   $ (28 )     --- %
Cost of revenue                                                
Ranor   $ 2,798       37 %   $ 2,919       38 %   $ (121 )     (4 )%
Stadco     3,833       50 %     3,586       47 %     247       7 %
Intersegment elimination     ---       --- %     (16 )     --- %     16       100 %
Consolidated Cost of revenue   $ 6,631       87 %   $ 6,489       85 %   $ 142       2 %
Gross profit (loss)                                                
Ranor   $ 1,512       20 %   $ 1,377       18 %   $ 135       10 %
Stadco     (521 )     (7 )%     (216 )     (3 )%     (305 )     (141 )%
Consolidated Gross profit   $ 991       13 %   $ 1,161       15 %   $ (170 )     (15 )%
                                                 

 

Nine Months Ended

 

    December 31, 2024     December 31, 2023     Changes  
          Percent of           Percent of              
  Amount     Revenue     Amount     Revenue     Amount     Percent  
Revenue                                                
Ranor   $ 13,482       55 %   $ 13,291       58 %   $ 191       1 %
Stadco     11,139       45 %     9,943       43 %     1,196       12 %
Intersegment elimination     (67 )     --- %     (243 )     (1 )%     176       72 %
Consolidated Revenue   $ 24,554       100 %   $ 22,991       100 %   $ 1,562       7 %
Cost of revenue                                                
Ranor   $ 9,215       38 %   $ 9,382       40 %   $ (167 )     (2 )%
Stadco     13,161       54 %     10,962       48 %     2,199       20 %
Intersegment elimination     (67 )     --- %     (243 )     (1 )%     176       72 %
Consolidated Cost of revenue   $ 22,309       92 %   $ 20,101       87 %   $ 2,208       11 %
Gross profit (loss)                                                
Ranor   $ 4,266       17 %   $ 3,703       16 %   $ 563       15 %
Stadco     (2,022 )     (8 )%     (813 )     (3 )%     (1,209 )     (149 )%
Consolidated Gross profit   $ 2,244       9 %   $ 2,890       13 %   $ (646 )     (22 )%

 

 


 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    Nine Months Ended December 31,  
(dollars in thousands)   2024     2023  
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net loss   $ (2,860 )   $ (1,921 )
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:                
Depreciation and amortization     2,093       1,759  
Amortization of debt issue costs     67       55  
Change in fair value of stock acquisition termination fee     419        
Stock-based compensation     40       196  
Change in contract loss provision     186       155  
Deferred income taxes     ---       (563 )
Gain on disposal of fixed assets     1       (40 )
Changes in operating assets and liabilities:                
Accounts receivable     401       144  
Contract assets     110       576  
Work-in-process and raw materials     50       (1,228 )
Other current assets     189       (305 )
Accounts payable     425       (497 )
Accrued expenses     (536 )     (527 )
Contract liabilities     (1,121 )     1,702  
Other noncurrent liabilities     (459 )     1,674  
Net cash (used in) provided by operating activities     (995 )     1,180  
CASH FLOWS FROM INVESTING ACTIVITIES:                
Proceeds from insurance claim on fixed assets     ---       62  
Purchases of property, plant, and equipment     (2,796 )     (2,782 )
Reimbursements for purchases of property, plant and equipment     2,566        
Net cash used in investing activities     (230 )     (2,720 )
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from private placement     1,801       ---  
Private placement fees     (213 )     ---  
Debt issue costs     (58 )     (40 )
Proceeds from equipment financing     65       ---  
Revolver loan borrowings     10,526       10,160  
Revolver loan payments     (10,381 )     (8,260 )
Payments of principal for leases     (7 )     (15 )
Repayments of long-term debt     (481 )     (448 )
Net cash provided by financing activities     1,252       1,397  
Net increase (decrease) in cash and cash equivalents     27       (143 )
Cash and cash equivalents, beginning of period     138       534  
Cash and cash equivalents, end of period   $ 165     $ 391  

 

 


 

EBITDA Non-GAAP Financial Measure

 

    Three Months ended December 31,     Nine Months ended December 31,  
(dollars in thousands)   2024     2023     Change     2024     2023     Change  
Net loss   $ (799 )   $ (865 )   $ 66     $ (2,860 )   $ (1,921 )   $ (939 )
Income tax benefit     ---       (240 )     240       ---       (563 )     563  
Interest expense (1)     147       110       37       392       353       39  
Depreciation and amortization     703       631       72       2,093       1,759       334  
EBITDA   $ 51     $ (364 )   $ 415     $ (375 )   $ (372 )   $ (3 )

 

 

(1) Includes amortization of debt issue costs.